<DOC>
	<DOCNO>NCT00210041</DOCNO>
	<brief_summary>The purpose study determine whether association Gemcitabine-Cisplatin effective treatment penis epidermoid carcinoma loco-regionally advanced metastatic .</brief_summary>
	<brief_title>Phase 2 Study Association Gemcitabine-Cisplatin Treat Penis Epidermoid Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Genital Neoplasms , Male</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Age ≥ 18 year OMS ≤ 2 Penis epidermoid carcinoma histologically prove . Tumor ganglionic locoregional injury inextirpable and/or metastatic ( M1 , T , N ) , initial diagnostic relapse first treatment curative aim ( surgery / radiotherapy ) Disease measurable RECIST criterion Absence former chemotherapy 5 year inclusion . If former radiotherapy , necessity appreciate target outside irradiation field . If former radiotherapy , must do 4 week inclusion study . Biologicals value require : polynuclear neutrophil ≥ 1500/mm3 , bloodplatelets ≥ 100000/mm3 , Hb ≥ 10 g/dl , Transaminases &lt; 3N , TP ≥ 70 % , total bilirubin &lt; 1,5 N , creatinine blood ≤ 110 micromoles/l . Normal clearance creatinine , accord Cockroft Gault 's formula . Calcemia : normal anomaly without clinical meaning . Wellinformed write consent , sign patient . Uncontrolled cerebral know metastasis All former chemotherapy administration 5 year inclusion Other cancer ( except basocellular cancer skin correctly treat , cancerous disease consider good prognosis remission 5 year least ) Uncontrolled cardiac insufficiency severe uncontrolled pathology . Peripheric neuropathy ≥ grade 2 OMS Anormal audiogram Patient difficult follow geographical , psychological family reason . Persons protect law .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Genital Neoplasms , Male</keyword>
</DOC>